BridgeMD
A study to assess the long-term safety and clinical activity of mRNA-3927 in participants previously enrolled in the mRNA-3927-P101 study
EU CTIS ID: 2022-502911-12-00
What this study is testing
Evaluate the long-term safety of mRNA-3927 administered to participants with PA who have previously participated in Study mRNA-3927-P101
- Phase I and Phase II (Integrated)- Other
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Participated in Study mRNA-3927-P101.
- Completed the EOT/ ET Visit in Study mRNA-3927-P101 and enroll in this study such that the first dose in this study is planned to be within 14±3 days of the last dose of mRNA-3927 in mRNA-3927-P101 study.
- Participant and/or legally authorized representative is willing and able to provide informed consent and/or assent as mandated by local regulations.
- Participant’s caregiver (and, if able to provide consent/assent, the participant) is willing and able to comply with study-related assessments.
You likely can't join if
- Not expected to receive clinical benefit from continued mRNA-3927 administration, in the opinion of the Investigator.
- Any clinical or laboratory abnormality or medical condition that, at the discretion of the Investigator, may put the individual at increased risk by participating in this study.
- History of liver and/or kidney transplant.
- Pregnant or breastfeeding.
- Sexually active and does not agree to use a highly effective method of contraception during the Treatment Period and for 3 months after the last dose of the mRNA-3927.
The study team makes the final eligibility decision.
Where it's taking place
- United States
- Canada
- United Kingdom
- Japan
- Saudi Arabia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0-17 years, 18-64 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include United States; Canada; United Kingdom; Japan; Saudi Arabia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.